🇺🇸 FDA
Patent

US 10513521

Compositions and methods for inhibiting BMP

granted A61PA61P21/00A61P29/00

Quick answer

US patent 10513521 (Compositions and methods for inhibiting BMP) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P21/00, A61P29/00, A61P3/06, A61P31/00